Gene · 7225
Papers2,972
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,972
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins. | Toxins (Basel) | 2026 | 41745735 | PubTator, text mining | PubMed |
| Engineered Exosomes: Advances in Therapeutic Applications for Otolaryngology-Head and Neck Diseases. | Int J Nanomedicine | 2026 | 41737047 | PubTator, text mining | PubMed |
| Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples. | Epigenomes | 2026 | 41718409 | PubTator, text mining | PubMed |
| ATP release mediated by TRPM3 enhances invasion in glioblastoma. | Anim Cells Syst (Seoul) | 2026 | 41710303 | PubTator, text mining | PubMed |
| Role of transient receptor potential channels on pathogenesis and treatment of psoriasis. | Inflammopharmacology | 2026 | 41689746 | PubTator, text mining | PubMed |
| A review of preclinical research on mechanically gated ion channels as therapeutic targets in neuropathic pain. | Ann Med | 2026 | 41656918 | PubTator, text mining | PubMed |
| Role of neutrophils in regulating vascular permeability in inflammatory and autoimmune diseases. | Inflamm Res | 2026 | 41653281 | PubTator, text mining | PubMed |
| EXPRESS: A Road to Recovery: Transient Receptor Potential (TRP) Channels as Therapeutic Avenues for Spinal Cord Injury. | Mol Pain | 2026 | 41622145 | PubTator, text mining | PubMed |
| TRPC6 inhibition: podocyte-targeted treatment for focal segmental glomerulosclerosis? | Lancet | 2026 | 41616796 | PubTator, text mining | PubMed |
| TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198. | Lancet | 2026 | 41616795 | PubTator, text mining | PubMed |
| Consanguinity-linked genetic variants in Algerian patients with steroid-resistant nephrotic syndrome: a familial study. | Pediatr Nephrol | 2026 | 41612037 | PubTator, text mining | PubMed |
| Gain-of-Function Variant TRPC6 A404V Is Associated With Doxorubicin-Related Cardiomyopathy. | Circ Genom Precis Med | 2026 | 41603030 | PubTator, text mining | PubMed |
| TRPC3 and TRPC6: Multimodal Cation-Conducting Channels Regulating Cardiovascular Contractility and Remodeling. | Cells | 2026 | 41597219 | PubTator, text mining | PubMed |
| Altitude hypoxia and hypoxemia: pathogenesis and management. | Signal Transduct Target Ther | 2026 | 41571626 | PubTator, text mining | PubMed |
| Engineered atopic dermatitis models for recreating hypoxic conditions in atopic dermatitis microenvironments. | Bioact Mater | 2026 | 41551767 | PubTator, text mining | PubMed |
| Urinary extracellular vesicle proteins for biomarker discovery in chronic kidney disease. | Kidney Res Clin Pract | 2026 | 41532152 | PubTator, text mining | PubMed |
| Functional Evaluation of TRPC6 Missense Variants in Cancer Patients via Molecular Docking Analysis Compared with Patch Clamp Electrophysiology. | bioRxiv | 2026 | 41509376 | PubTator, text mining | PubMed |
| Structural and functional insights of the podocyte slit diaphragm complex. | Tissue Barriers | 2026 | 41100809 | PubTator, text mining | PubMed |
| Staple oligomers induce a stable RNA G-quadruplex structure for protein translation inhibition in therapeutics. | Nat Biomed Eng | 2026 | 41094015 | PubTator, text mining | PubMed |
| Targeting TRPC6 in podocytopathies: Why clinical translation remains a challenge? | Pharmacol Rep | 2026 | 40719843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7225/papers?page=3